Add Yahoo as a preferred source to see more of our stories on Google. Watch: 'I thought I had a bad case of thrush - it turned out to be rare vulval cancer' When Pippa Sharp spotted a sore on her left ...

A patient turned advocate underscores the importance of education, especially for those facing a rare cancer. Stacey Hudson Padova had never heard of vulvar cancer until she received a diagnosis in ...

Vulvar melanoma is a rare type of cancer that develops in the skin of your vulva. Early symptoms include a lump or growth, itching, and color changes. Melanoma is a type of skin cancer. It starts in ...

Gynecological cancers affect the reproductive organs of people who were assigned female at birth (AFAB). They include cancers of the: Cervix Ovaries Uterus Vagina Vulva A sixth type is a very rare ...

Prior Authorization and Association With Delayed or Discontinued Prescription Fills Epidemiologic data showed a recent rise in incidence of VC, attributed to human papillomavirus. Surgery is the ...

Due to its location, vaginal cancer doesn’t usually cause changes that you can see. Later stage vaginal cancer occasionally causes a mass deep inside your vaginal canal up by your cervix. In some ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the ...

Vulvar mucosal melanoma is a form of cancer that develops in the cells of the mucus membranes in the vulva. Symptoms include unexpected bleeding, vaginal pain, unusual discharge, itching, and a lump ...

At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer, day in and day out. A handful of people form the core of your care team. You have an oncologist who ...

Non-Overlapping and Non–Cell-Type–Specific Gene Expression Signatures Predict Lung Cancer Survival A multicenter observational study on sentinel node detection using radioactive tracer and blue dye ...

With a market size anticipated to expand from $0.62 billion in 2025 to $0.67 billion in 2026 at a compound annual growth rate ...

The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...